1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Surveillance after resection of pancreatic ductal adenocarcinoma : How to do it and what are the benefits?
(
- Contribution to journal › Article
-
Mark
E2F transcription factors promote tumorigenicity in pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
- 2022
-
Mark
Pancreatic cancer–the past, the present, and the future
(
- Contribution to journal › Scientific review
-
Mark
Lipid Metabolic Reprogramming Extends beyond Histologic Tumor Demarcations in Operable Human Pancreatic Cancer
(
- Contribution to journal › Article
- 2020
-
Mark
Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas
(
- Contribution to journal › Article
- 2008
-
Mark
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers
(
- Contribution to journal › Scientific review